$5.28
-0.11-2.04%
In chiusura: Nov 24, 4:00 PM EST
$5.38
0.11.89%
Pre-mercato: 8:16 AM EST
Organogenesis Holdings segnala gli utili su base trimestrale. Questi report sugli utili trimestrali offrono agli investitori uno sguardo ai risultati finanziari di un'azienda per un periodo di 3 mesi. I report sugli utili includono quasi sempre i risultati EPS e i ricavi.
Analizza lo storico degli utili di Organogenesis Holdings utilizzando ordinamenti e filtri avanzati.
Get Alert | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
ORGO | Organogenesis Hldgs | $0.07 | $0.21 | — | — | $126.66M | $172.65M | — | — | 02/26/2026 | |
ORGO | Organogenesis Hldgs | $0.10 | $0.07 | $0.18 | 152.86% | $115.18M | $134.10M | $150.86M | 12.50% | 11/06/2025 | |
ORGO | Organogenesis Hldgs | $0.00 | -$0.01 | -$0.06 | -500.00% | $130.23M | $104.75M | $100.78M | -3.79% | 08/07/2025 | |
ORGO | Organogenesis Hldgs | -$0.01 | -$0.03 | -$0.11 | -253.33% | $109.98M | $90.77M | $86.70M | -4.48% | 05/08/2025 | |
ORGO | Organogenesis Hldgs | $0.01 | $0.02 | $0.07 | 250.00% | $99.65M | $109.60M | $126.66M | 15.56% | 02/27/2025 | |
ORGO | Organogenesis Hldgs | $0.04 | -$0.01 | $0.10 | 1100.00% | $108.53M | $108.83M | $115.18M | 5.83% | 11/12/2024 | |
ORGO | Organogenesis Hldgs | $0.05 | $0.00 | $0.00 | — | $117.32M | $121.85M | $130.23M | 6.88% | 08/08/2024 | |
ORGO | Organogenesis Hldgs | -$0.01 | -$0.03 | -$0.01 | 66.67% | $107.64M | $101.05M | $109.98M | 8.83% | 05/09/2024 | |
ORGO | Organogenesis Hldgs | $0.07 | $0.01 | $0.01 | 0.00% | $115.52M | $109.05M | $99.65M | -8.62% | 02/29/2024 | |
ORGO | Organogenesis Hldgs | $0.04 | $0.00 | $0.04 | 100.00% | $116.86M | $111.40M | $108.53M | -2.58% | 11/09/2023 | |
ORGO | Organogenesis Hldgs | $0.09 | $0.02 | $0.05 | 150.00% | $121.40M | $115.10M | $117.32M | 1.93% | 08/09/2023 | |
ORGO | Organogenesis Hldgs | $0.01 | -$0.02 | -$0.01 | 50.00% | $97.12M | $95.50M | $107.64M | 12.71% | 05/10/2023 | |
ORGO | Organogenesis Hldgs | $0.40 | $0.05 | $0.07 | 40.00% | $128.56M | $122.40M | $115.52M | -5.62% | 03/01/2023 | |
ORGO | Organogenesis Hldgs | $0.10 | $0.06 | $0.04 | -33.33% | $113.75M | $120.85M | $116.86M | -3.30% | 11/09/2022 | |
ORGO | Organogenesis Hldgs | $0.15 | $0.08 | $0.09 | 12.50% | $123.20M | $120.90M | $121.40M | 0.41% | 08/09/2022 | |
ORGO | Organogenesis Hldgs | $0.07 | $0.05 | $0.01 | -80.00% | $102.55M | $95.93M | $98.12M | 2.28% | 05/10/2022 | |
ORGO | Organogenesis Hldgs | $0.15 | $0.08 | $0.40 | 400.00% | $106.81M | $124.70M | $128.56M | 3.09% | 03/01/2022 | |
ORGO | Organogenesis Hldgs | $0.19 | $0.06 | $0.10 | 66.67% | $100.80M | $112.67M | $113.75M | 0.96% | 11/09/2021 | |
ORGO | Organogenesis Hldgs | -$0.05 | $0.07 | $0.15 | 114.29% | $68.96M | $107.30M | $123.20M | 14.81% | 08/09/2021 | |
ORGO | Organogenesis Hldgs | -$0.16 | -$0.02 | $0.07 | 450.00% | $61.73M | $87.57M | $102.55M | 17.11% | 05/10/2021 | |
ORGO | Organogenesis Hldgs | -$0.04 | $0.13 | $0.16 | 23.08% | $74.64M | $99.18M | $106.81M | 7.69% | 03/16/2021 |
| Trimestre fiscale | Data segnalata | EPS effettivo | EPS stimato | Sorpresa% |
|---|---|---|---|---|
| Q3 | 2025-11-06 | $0.18 | $0.07 | 152.9 % |
| Q2 | 2025-08-07 | $-0.06 | $-0.01 | -500.0 % |
| Q1 | 2025-05-08 | $-0.11 | $-0.03 | -253.3 % |
| Q4 | 2025-02-27 | $0.07 | $0.02 | 250.0 % |
| Trimestre fiscale | Data segnalata | Entrate effettive | Entrate stimate | Sorpresa% |
|---|---|---|---|---|
| Q3 | 2025-11-06 | $150.86M | $134.10M | 12.5 % |
| Q2 | 2025-08-07 | $100.78M | $104.75M | -3.79 % |
| Q1 | 2025-05-08 | $86.70M | $90.77M | -4.48 % |
| Q4 | 2025-02-27 | $126.66M | $109.60M | 15.6 % |
Si prevede che Organogenesis Holdings (ORGO) fornisca risultati il febbraio 26, 2026. Gli ultimi risultati sono stati pubblicati il novembre 6, 2025 per il Q3.
L'EPS effettivo era $0.18, che superato la stima di $0.07.
Le entrate effettive sono state $150.9M, che superato la stima di $134.1M.
Sfoglia stime sugli utili, EPS e ricavi su tutte le azioni.